Related Experiment Video
Updated: Sep 21, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Management of IgA Nephropathy in Pediatric Patients
1Department of General Pediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, Medical Center, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany.
Insights
Pediatric IgA nephritis (IgAN) can lead to chronic kidney disease. Corticosteroid treatment showed significant proteinuria reduction in most young patients, suggesting unified treatment approaches may be effective.
Area of Science:
- Pediatric Nephrology
- Immunology
- Glomerular Diseases
Background:
- IgA nephritis (IgAN) in children and adolescents frequently progresses to chronic kidney disease.
- Evidence-based treatment guidelines for pediatric IgAN are lacking.
- Long-term renal function decline is a known complication in this demographic.
Purpose of the Study:
- To evaluate the efficacy of corticosteroid treatment in pediatric IgA nephritis.
- To explore the potential for unified treatment protocols for IgA nephritis and IgA vasculitis nephritis in children.
- To report clinical data from a cohort of pediatric IgAN patients.
Main Methods:
- Retrospective analysis of 22 pediatric patients diagnosed with IgA nephritis via biopsy.
- Treatment with corticosteroids administered to 14 patients based on German Society of Pediatric Nephrology guidelines for IgA nephritis vasculitis.
- Assessment of treatment outcomes, focusing on proteinuria reduction.
Main Results:
- A majority of treated patients showed clinical improvement.
- Significant reduction in proteinuria was observed within five months of corticosteroid therapy initiation.
- The study provides preliminary data on treatment response in pediatric IgAN.
Conclusions:
- Corticosteroid therapy appears beneficial for pediatric IgA nephritis, leading to significant proteinuria reduction.
- Findings suggest that current treatment recommendations for acute IgA nephritis and IgA vasculitis nephritis might be applicable to pediatric IgAN.
- Further research is warranted to establish unified, evidence-based treatment guidelines for pediatric IgAN.
Abstract:
The onset of IgA nephritis in childhood and adolescence often develops into chronic glomerulonephritis with declining renal function. Although these long-term consequences are known, there is still a lack of evidence-based treatment recommendations in this age group. We report data from 22 pediatric patients who were biopsied to confirm the diagnosis of IgAN at our clinical center. 14 of them were treated with corticosteroids according to the recommendations for IgA nephritis vasculitis of the German Society of Pediatric Nephrology (GPN). Improvement was achieved in the majority of all cases, with a significant reduction in proteinuria five months after initiation of therapy. Our data suggest that treatment regimens for acute IgA nephritis and IgA vasculitis nephritis may be unified and are discussed in the context of current studies.
More Related Videos
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Kidney Transplant II: Surgical Procedure

